Cancer Patients Can Now Read a Molecular Analysis of Their Cancer That They Can Understand
Perthera, Inc. has developed a report empowering cancer patients to make informed decisions regarding their treatment options. The whole point of precision medicine is to tailor treatment to the specific needs of the patient.